Clinical Trials Browser

Phase 2 × Cancer Cachexia × ruxolitinib × Clear all

NCT02072057 2019-02-28

Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.

Phase 2 Terminated

Cancer Cachexia